An NCI-designated Comprehensive Cancer Center

Elizabeth Lihua Budde, M.D., Ph.D.

Hematologist - Oncologist
Clinical Expertise
Research Focus
  • Immunotherapies for Leukemia and Lymphoma
Appointments
Assistant Professor, Department of Hematology & Hematopoietic Cell Transplantation
Other Languages Spoken
  • English
  • Mandarin

Clinical Teams

Elizabeth Budde, M.D., Ph.D., is an assistant professor in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope. Dr. Budde's academic and clinical interests include investigating and designing novel means of immunotherapy for patients with lymphoma and leukemia, and she is part of the T Cell Therapeutics Research Laboratory, investigating the use of CAR T cells to treat blood cancers and other diseases.
 
Board certified in medical oncology and internal medicine, Dr. Budde has received many honors and awards for her work. She was chosen as a Special Fellow in Clinical Research awardee by the Leukemia & Lymphoma Society, a recipient of the Edson Immunotherapy Pilot Award from the J. Orin Edson Foundation and an awardee of the Stop Cancer Foundation seed grant in 2016. She is also a recipient of the prestigious Damon Runyon Cancer Research Foundation Clinical Investigator Award (2014-2017). She has served as the principal investigator on several innovative translational research protocols and has published her work in many peer-reviewed journals, and given presentations at national and international meetings.

Locations

City of Hope Comprehensive Cancer Center, 1500 East Duarte Road

Duarte, CA 91010

In The News
An Expert's Voice
T cell therapy

New Immunotherapy Research Presented at ASH

breakthroughs - t cells

New Immunotherapy Research Presented at ASH Annual Meeting 2019

T cell therapy

New immunotherapies detailed at ASH conference